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Abstract 
Cognitive functions such as attention and memory are known to be impaired in End Stage 
Renal Disease (ESRD), but the sites of the neural changes underlying these impairments are 
uncertain. Patients and controls took part in a latent learning task, which had previously 
shown a dissociation between patients with Parkinson’s disease and those with medial 
temporal damage.  ESRD patients (n=24) and age and education-matched controls (n=24) 
were randomly assigned to either an exposed or unexposed condition. In Phase 1 of the task, 
participants learned that a cue (word) on the back of a schematic head predicted that the 
subsequently seen face would be smiling. For the exposed (but not unexposed) condition, an 
additional (irrelevant) colour cue was shown during presentation. In Phase 2, a different 
association, between colour and facial expression, was learned. Instructions were the same 
for each phase: participants had to predict whether the subsequently viewed face was going to 
be happy or sad. No difference in error rate between the groups was found in Phase 1, 
suggesting that patients and controls learned at a similar rate. However, in Phase 2, a 
significant interaction was found between group and condition, with exposed controls 
performing significantly worse than unexposed (therefore demonstrating learned irrelevance). 
In contrast, exposed patients made a similar number of errors to unexposed in Phase 2. The 
pattern of results in ESRD was different from that previously found in Parkinson’s disease, 
suggesting a different neural origin.  
Index words: End stage renal disease (ESRD); Cognitive impairment; Learning; Cortical 
dysfunction 
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1.1 Introduction 
End Stage Renal Disease (ESRD) occurs when the kidneys (responsible for controlling the 
water and ionic balance of the body) are functioning at approximately less than 15% of their 
normal level. UK estimates suggest that approximately 55,000 patients are currently 
receiving treatment for ESRD (UK Renal Registry 14
th
 Annual Report, 2013). In addition to 
the physiological problems associated with the disease, cognition is also known to be 
impaired in these individuals (Hart & Kreutzer, 1988). Although the exact pathophysiology 
of the deficit is not yet fully understood, a number of functions have been found to be 
impaired. Elias et al. (2009) demonstrated that patients with a lower Glomerular Filtration 
Rate (GFR) function (standardised measure of kidney functioning) were poorer on tests of 
visual-spatial memory, working memory, concentration and attention. Lux et al. (2010) 
suggested that language areas, also located in the temporal cortex, responsible for word 
fluency and verbal comprehension, may also be impaired in ESRD patients. Other cognitive 
processes found to be worse in ESRD are planning (Murray, Pederson & Tupper, 2007), 
attention and task-switching (Griva, Newman & Harrison, 2003), and inhibition (Williams, 
Sklar, Burright & Donovick, 2004), all usually classified as executive functions and thought 
to be modulated by the frontal lobes (Stuss & Knight, 2013; Tranel, Anderson & Benton, 
1994). However, more recently, there have been opposing views in the literature, suggesting 
that other areas, both cortical and subcortical, may be contributing to such executive tasks in 
ESRD (Alvarez & Emory, 2006; Miller & Cummings, 2007). Duke and Kaszniak (2000) 
suggested that poorer executive functioning cannot be labelled as a solely “frontal lobe 
deficit”: projections from frontal lobe areas to temporal, parietal and even subcortical areas 
may be having a modulatory effect during executive functioning tasks. Thus, at present, there 
is disagreement about the origin of the cognitive dysfunction demonstrated in ESRD. 
At present, evidence on the neural changes underlying impairments in ESRD is limited. At 
this stage, it seems appropriate to initially examine broader distinctions between brain 
regions, with the expectation that this would allow more targeted investigations in the future. 
A key distinction often made in relation to other neurological disorders such as Alzheimer’s 
disease (AD) and Parkinson’s disease (PD), is that between cortical and subcortical 
structures. Although the majority of the behavioural data in ESRD suggests a cortical 
impairment (Kurella, Chertow Luan & Yaffe, 2004; Lux et al., 2010; Sarnak et al., 2013), 
there have also been proposals that the pattern of the impairment matches that of a subcortical 
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deficit (Harciarek et al., 2010; Pereira et al., 2007). We attempted to distinguish between 
these possibilities with a dissociation paradigm developed by Myers et al. (2003).  
Elucidating the relative contributions of different brain regions to the impairments may allow 
firmer comparisons between ESRD and other neurological disorders.  
Myers et al. (2003) showed a dissociation between patients with medial temporal (cortical) 
and those with basal ganglia (subcortical) damage using a latent learning task. This task was 
split into two phases. In the first phase, two groups of participants learn to associate one 
stimulus with another, with one (‘exposed’) group being exposed to an additional 
uncorrelated cue. In the second phase, participants learn a new association between stimuli, in 
which the previously uncorrelated cue (observed by the ‘exposed’ group) now becomes 
relevant. Healthy controls exposed to such irrelevant cues in Phase 1 were slower to learn 
subsequent associations in Phase 2, in which the cue had become relevant, than were controls 
that had no prior exposure (an effect labelled ‘learned irrelevance’). However, patients with 
medial temporal (MT) damage did not show any effect of exposure in Phase 1: both exposed 
and non-exposed groups learnt at the same rate. In contrast, patients with basal ganglia 
damage (PD patients) showed the opposite effect to the controls: patients who were exposed 
in Phase 1 learnt at a faster rate in Phase 2 than those who were not exposed to the initially 
irrelevant stimuli. One should be cautious in ascribing the differences between the groups to 
particular brain areas, since it is difficult to rule out the possibility of more widespread 
abnormality in the patient groups, an issue which we take up in the Discussion. Nevertheless, 
at first sight, these three distinct patterns of response suggest dissociable contributions from 
the medial temporal lobe and basal ganglia to learning and memory. Although the exact 
mechanisms underlying the different effects are not yet fully understood, they suggest that the 
task may be useful in identifying cortical and subcortical contributions to impairments in 
cognitive performance. 
We measured the performance of a group of ESRD patients and a matched healthy control 
group on the test of latent learning. Although the experimental design was the same as in the 
Myers et al. (2003) study, the stimuli were different, allowing easier production and 
instruction to participants. We expected to replicate the finding of Myers et al. that healthy 
controls learn more slowly after prior exposure to the initially uncorrelated stimulus than 
after no previous exposure (in other words, show ‘learned irrelevance’). Because the latent 
learning task has been run on other patient groups, we can compare the results of ESRD 
patients with those from other disorders in which the sites of damage are better understood. If 
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the changes underlying impairments in ESRD patients are indeed cortical, their latent 
learning should be more like that of MT than that of PD patients.  
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1.2 Material and methods 
1.2.1 Participants 
Twenty-four patients (mean age: 67.5 years, S.D: 13.7) were recruited from the renal unit at 
the Royal Berkshire Hospital, Reading, UK. ESRD patients had been receiving haemodialysis 
(HD) treatment three times per week for 3-5 hours per treatment, for >90 days prior to testing 
(Kt/v > 1.4). Patients were deemed eligible for the study by the treating nephrologist who 
informed them about the study and obtained consent. Patients were excluded if they had any 
prior history of ophthalmological or neurological illness. Testing was conducted in a quiet 
office located on the renal ward. 
Twenty-four healthy control participants (mean age: 67.8 years, S.D: 13.1) were recruited 
from a research panel maintained by the University of Reading. Control participants were 
individually matched to patients on age, sex and education level. Participants were tested in a 
quiet room in the School of Psychology and Clinical Language Sciences. 
 
1.2.2 Apparatus & Materials 
Stimuli were presented on a Toshiba 17.3” LCD screen laptop computer using custom 
software written in E-Prime (v2.0). The participant was seated in a comfortable chair 
positioned approximately 45cm from the screen. In addition to the primary task, all 
participants completed the Mini Mental State Examination (MMSE), the Instrumental 
Activity of Daily Living scale (IADL), the National Adult Reading Test (NART), an 
estimator of pre-morbid  IQ, and the Geriatric Depression Scale (GDS). 
 
1.2.3 Stimuli 
On each trial, participants were presented with a circle (representing the back of a person’s 
head), with a speech bubble above containing a word printed in black lowercase letters (see 
Figure 1.1A).  The words were taken from the list of 30 monosyllabic non-words used by 
Myers et al. For each participant, 15 words were randomly selected and used in Phase 1, with 
the remaining 15 words used in Phase 2 (see Appendix A for word list). In Phase 1 the word 
“melk” was the signal word, W, that predicted a ‘happy’ face, whereas all the other 14 words 
predicted a ‘sad’ face. The circle could be coloured red or green, or uncoloured (white), 
however, in Phase 1 the colour was unrelated to the happiness of the face. In Phase 2, either 
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red or green was selected to be colour C+ which predicted a ‘happy’ face, whilst the other 
colour was colour C- which predicted a ‘sad’ face. Colours were counterbalanced, so that red 
was colour C+  for half of participants, and green was colour C+ for the other half. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Example of the screen appearance at: (A) the start of each trial (B) after the 
participant responds correctly. 
 
1.2.4 Design and Procedure 
Participants in both the control and patient groups were randomly assigned to either an 
exposed (n=12) or unexposed (n=12) group. All participants took part in Phase 1 and Phase 2 
of the experiment.  
(A) 
(B) 
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Before Phase 1 began, participants were told that they would view a series of back views of 
heads, so the face would not be visible. Their task would be to predict whether the face to be 
shown would be happy or sad when the head turned around. On each trial, the back of the 
head, speech bubble and word appeared together, with a question underneath, “Is this a happy 
or sad face?”. The participant responded by pressing one of two keys (‘a’ for happy, and ‘l’ 
for sad). The face (either ‘happy’ or ‘sad’) was then shown, together with corrective feedback 
(see Figure 1.1B).  
Phase 1 consisted of 30 trials. During 15 randomly selected trials, the signal word, W, 
(“melk”) was presented, and the ‘happy’ face appeared after the participant had responded. 
On the remaining 15 trials, the other words were presented in a random order and a ‘sad’ face 
appeared. In Phase 1, the signal word, “melk”, perfectly predicted the appearance of a 
‘happy’ face. For participants in the Phase 1 exposed group, the head appeared in colour C+ 
for 15 trials and in colour C- for 15 trials, but colour and facial expression were randomly 
paired. For participants in the unexposed condition, the head was always uncoloured (white).  
Phase 2 began about 1 minute after the end of Phase 1 (the time needed to close one program 
and download the other). The faces used in Phase 1 were also shown during Phase 2, but in 
the second phase colour predicted facial expression perfectly. Phase 2 consisted of 60 trials, 
split into four blocks of 15 trials. Between each block, participants were given a short break. 
Each of the 15 monosyllabic non-words occurred once in each block, in a randomised order, 
but the words were related to the subsequent facial expression. In Phase 2, colour C+ 
occurred randomly on five trials per block, with colour C- occurring on the remaining 10 
trials. Colour C+ was predictive of (correlated with) a subsequent ‘happy’ face, whereas 
colour C- was predictive of (correlated with) a ‘sad’. In Phase 2, the previously predictive 
words were now irrelevant to the prediction of facial expression. 
In both phases of the task, number of errors was used as the measure of performance. In 
Phase 2, participants were deemed to have reached learning criterion if 10 consecutive correct 
responses were made (with consecutive responses across blocks being recognised), 
whereupon Phase 2 was terminated. Criterion cut off was included to prevent errors occurring 
due to boredom with the task. 
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1.3 Results 
1.3.1 Demographics 
Table 1.1 shows participants’ means and standard deviations for age, years of education, 
NART overall IQ, GDS, MMSE and IADL score, split by group and condition. Higher scores 
reflect better performance, except for the GDS in which a higher score reflects a greater sign 
of depression. A 2 (patient vs. controls) x 2 (exposed vs. unexposed) between subjects 
ANOVA found no main effect of group (patients vs controls) for age (F(1, 44) = 0.004, p = 
0.949), years of education (F(1, 44) = 0.149, p = 0.701), MMSE (F(1, 44) = 2.521, p = 
0.120), or NART (F(1, 44) = 2.452, p = 0.125). However, a main effect of group was found 
for GDS (F(1, 44) =8.686, p = 0.005) and IADL score (F(1, 44) =18.109, p < 0.001). No 
significant main effect was found of condition (exposed vs unexposed) for age (F(1, 44) = 
0.002, p = 0.966), years of education (F(1, 44) = 0.003, p = 0.956), MMSE (F(1, 44) = 1.120, 
p = 0.296), NART (F(1, 44) = 1.318, p = 0.257) or IADL (F(1, 44) = 0.637, p = 0.429). 
However, a significant main effect was found for GDS score (F(1, 44) = 4.503, p = 0.04). No 
significant interactions were found involving age (F(1, 44) = 0.837, p = 0.365), years of 
education (F(1, 44) = 0.003, p = 0.956), MMSE (F(1, 44) = 0.124, p = 0.726), NART (F(1, 
44) = 0.338, p = 0.564), GDS (F(1, 44) = 0.347, p = 0.559) or IADL (F(1, 44) = 0.637, p = 
0.429).  
Although there was a significant difference between patient and control IADL scores, the 
mean patient score and all individual patient scores were within the normal range. Despite the 
significant differences in GDS scores, the mean patient GDS score was within the normal 
range, though the individual scores for 3 patients were consistent with a moderate level of 
depression. We consider below whether these differences between groups might have 
influenced the results of the latent learning task. Table 1.2 provides further information on 
ESRD patients’ initial diagnoses, comorbidities and the duration of time that patients have 
been receiving haemodialysis. 
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Table 1.1. Demographic information for patient and control groups – split by condition. 
 
 
 
 
 
 
 
 
 
                           Group (exposed)  
Patient (n = 12) Control (n = 12)  
Mean SD Mean SD  
Age 65.8 14.6 69.7 14.3  
Education 11.8 2.7 12.0 2.5  
MMSE 27.8 2.1 28.3 1.1  
NART Overall IQ 114.5 6.3 119.6 5.1  
GDS 4.8 2.8 2.3 1.5  
IADL 6.9 1.5 8.0 0.0  
M / F 8 4 7 5  
                          Group (unexposed) 
 Patient (n = 12) Control (n = 12)  
 Mean SD Mean SD  
Age 69.3 13.2 65.9 11.9  
Education 11.8 2.7 12.1 2.6  
MMSE 28.1 2.1 29.0 1.0  
NART Overall IQ 105.6 33.9 116.7 6.8  
GDS 2.8 3.6 1.2 1.2  
IADL 6.4 1.6 8.0 0.0  
M / F 7 5 8 4  
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Table 1.2. ESRD patient group characteristics 
 
  
 
Haemodialysis Patients (n = 24) 
Characteristic No. of Patients 
Percentage or Mean 
± SD 
Age (yr)   
<55 4 16.7 
55-64 6 25.0 
65-74 5 20.8 
75-85 8 25.0 
>85 1 12.5 
Mean  67.5 ± 13.7 
Dialysis Duration (months)   
0-12 3 12.5 
13-24 6 25.0 
>24 15 62.5 
Mean  50.6 ± 60.4 
Cause of ESRD   
Type 2 diabetes mellitus 
 
3 12.5 
Type 1 diabetes mellitus 1 4.2 
Adult polycystic kidney disease 4 16.7 
Chronic kidney disease (unknown cause) 4 16.7 
Obstructive uropathy 2 8.3 
Glomerulonephritis 
 
 
6 25.0 
Vasculitis 2 8.3 
Hypertensive/renovascular disease 1 4.2 
Surgical loss 1 4.2 
Comorbid Conditions   
Peripheral vascular disease 7 29.2 
Diabetes 8 33.3 
Hypertension 17 70.8 
Stroke 3 12.5 
Myocardial infarction 1 4.2 
12 
 
1.3.2 Patients vs. Controls 
Figure 1.2 shows the mean number of errors during Phase 1 and Phase 2 for both patients and 
controls. Due to the non-normal nature of the distribution of scores, log transformations were 
performed to normalise the data to enable parametric tests to be carried out (raw scores will 
still be presented throughout to show mean differences). A 2 (patient vs control) x 2 (exposed 
vs unexposed) x 2 (Phase 1 vs Phase 2) between subjects ANOVA showed a main effect of 
group, F(1, 88) = 5.246, p = 0.024, and condition F(1, 88) = 18.75, p < 0.001, but no main 
effect of phase, F(1, 88) = 0.069, p = 0.794. The only significant interaction found was 
between group and condition, F(1, 88) = 4.608, p = 0.035. All other interactions were non-
significant: group x phase, F(1, 88) = 0.008,  p = 0.930, condition x phase, F(1, 88) = 1.134, 
p = 0.290, and group x condition x phase, F(1, 88) = 2.459, p = 0.120. Removing the 3 
patients with elevated GDS scores did not alter the pattern of significance of the main effects 
or interactions, and so their data were retained. In subsequent analyses, Phase 1 and Phase 2 
were analysed separately to determine exactly what was driving the main effect of group and 
condition (as in Myers et al., 2003).  GDS and IADL scores were included in the analyses as 
covariates, because of the inter-group differences in these variables. Because of the wide 
range of ages of participants, and the possibility that age was affecting latent learning, age 
was also included as a covariate. For Phase 1 there was a main effect of group, F(1, 41) = 
7.109, p = 0.011, and condition, F(1, 41) = 7.134, p = 0.011. However, there was no 
significant interaction found between group x condition, F(1, 41) = 0.404, p = 0.529, 
suggesting that patients were performing similarly to controls during Phase 1.  None of the 
covariates had a significant effect (for age, F(1, 41) = 1.415, p = 0.241, for IADL, F(1, 41) = 
0.686, p = 0.412, and for GDS, F(1, 41) = 0.541, p = 0.466). For Phase 2, there was no main 
effect of group, F(1, 41) = 0.341, p = 0.563, but there was a main effect of condition, F(1, 41) 
= 6.733, p = 0.013, and a significant group x condition interaction, F(1, 41) = 4.986, p =.031. 
As in Phase 1, none of the covariates had a significant effect (for age, F(1, 41) = 0.467, p = 
0.498, for IADL, F(1, 41) = 0.086, p = 0.77, and for GDS, F(1, 41) = 1.112, p = 0.298). 
Independent t-tests, with Bonferroni correction, revealed controls to be making significantly 
fewer errors during the un-exposed condition (M = 5.67, SD = 9.88) than the exposed 
condition (M = 18.58, SD = 11.20) during Phase 2 (t(22) = 4.01, p = .004). In contrast, the 
patient un-exposed (M = 14.17, SD = 12.47) and exposed group (M = 16.50, SD = 12.21) did 
not differ significantly during Phase 2 (t(22) = 0.608, p >0.9). An exposure effect observed in 
the control group is not apparent in the patient group.  
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Figure 1.2. Total number of errors made during Phase 1 and Phase 2 for both patients and 
controls in each condition. Error bars = ±1 S.E. 
 
 
Figure 1.3 shows the percentage of participants who reached criterion during Phase 2. To 
determine if participants were reaching criterion differently, dependent on condition, Chi-
squared tests were carried out. In the control group, there was no significant difference 
between the number of participants who reached criterion in the un-exposed condition and 
the exposed condition (χ2(1) = 3.00, p =.083). In the patient group, there was absolutely no 
difference between the number of participants reaching criterion in the un-exposed condition 
compared to the exposed condition (χ2(1) = 0.00, p =1.0). Irrespective of condition, patients 
reached criterion exactly the same number of times. 
To summarise, patients were responding in a similar way to controls during Phase 1 in each 
condition, however, during Phase 2, the exposure effect observed in the control group was 
not evident in the patient group: exposure condition did not impact on patient error rate. 
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Figure 1.3. Total percentage of participants reaching criterion in Phase 2.  
 
 
 
1.3.3 Correlations 
The absence of learned irrelevance in the ESRD group suggests that patients are processing 
the stimuli in a qualitatively different way. However, due to the lower IADL score and, more 
importantly, the higher GDS score observed in the ESRD group, it is possible that the 
impairment abolishing learned irrelevance in the latent learning task is a consequence of 
patients’ general cognitive status rather than an effect of ESRD. For example, high 
depression levels have been associated with impaired verbal and non-verbal learning, 
concentration, attention and retention (for a review see Veiel, 1997). To investigate this 
possibility, Spearman correlations were calculated between scores on Phase 2 of the latent 
learning task (in which patients and controls differed) and age, education level, MMSE, 
NART, GDS and IADL score. Correlations were calculated separately for the patient and 
control group and split by condition (exposed vs unexposed). See Table 1.3 for correlations 
and p-values. None of the Spearman correlations was significant, suggesting that the major 
factor driving this difference is ESRD.  
The correlations between age and errors in Phase 2, though insignificant, were negative in 
patients and positive in controls in both the exposed and unexposed groups. When the scores 
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from the exposed and unexposed groups were combined, the correlations were still 
insignificant (for patients, r = 0.28, p = 0.19; for controls, r = 0.30, p = 0.16).  
 
Table 1.3. Spearman correlation coefficients (p-value in brackets) between Phase 2 mean 
errors and measures of cognition and mood (split by condition). No significant correlations 
were found. 
MMSE = Mini Mental State Examination, NART = National Adult Reading Test, IADL = Instrumental Activities of Daily Living, GDS = 
Geriatric Depression Score. Two-tailed correlations were calculated separately for each group. *** = correlation could not be conducted due 
to lack of variance between scores, with all controls and patients in the unexposed groups achieving the maximum score (within the exposed 
groups, all IADL scores were within the normal range). 
 
 
                                                                       Patient Group 
 Age Education MMSE NART IADL GDS 
Exposed 
-.539 
(.071) 
.055 
(.866) 
.570 
(.053) 
-.088 
(.786) 
.261 
(.412) 
(-.278) 
.382 
Unexposed 
-.170 
(.598) 
-.250 
(.434) 
.257 
(.421) 
-.209 
(.515) 
*** 
*** 
-.373 
(.232) 
                                                                        Control group 
 Age Education MMSE NART IADL GDS 
Exposed 
.467 
(.126) 
-.075 
(.817) 
.329 
(.297) 
.161 
(.616) 
-.169 
(.600) 
.106 
(.742) 
Unexposed 
.390 
(.210) 
-.179 
(.578) 
-.311 
(.326) 
-.215 
(.502) 
*** 
*** 
.344 
(.274) 
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1.3.4 Possible effect of hypertension 
As Table 1.2 shows, ESRD is often associated with comorbidities. In the present patient 
group, one comorbidity, namely hypertension, was present in sufficiently large numbers to 
make a comparison possible between patients with and without this symptom. However, no 
main effect of hypertension was found for the data in Phase 1 (F(1,20) = 1.542, p = 0.229), or 
in Phase 2 (F(1,20) = 0.044, p = 0.836). In addition, no significant interaction between 
hypertension and condition was found in either Phase 1 (F(1,20) = 0.921, p = 0.349) or Phase 
2 (F(1,20) = 0.642, p = 0.432). 
 
1.4 Discussion 
 
This study aimed to advance knowledge of the nature of the deficit underlying cognitive 
impairments in ESRD. To investigate this, a latent learning task, previously showing a 
dissociation between patients with medial temporal and basal ganglia damage, was employed. 
In line with Myers et al. (2003), controls showed an exposure effect: learning was slower in 
the exposed compared to the un-exposed condition. These findings mimic the results of 
studies investigating the effect of learned irrelevance (Dess & Overmier, 1989; Maes, Dame 
& Eling, 2004). Baker (1976) suggests that due to the unfamiliar setting, an expectation arises 
that two cues are unrelated to one another which perseverates into subsequent phases of the 
task, resulting in slower learning when stimuli do become relevant.  
In the ESRD group, patients learned at the same rate, irrespective of exposure: the number of 
errors in the exposed group was the same as that in the un-exposed group. Patients’ overall 
learning rate, in both conditions, was similar to the rate of controls’ exposed learning rate. 
The main difference between the control and the patient groups was in how they responded 
during the un-exposed condition, since novel prior exposure did not influence patient learning 
rate.  
Although there was a similar lack of effect of exposure in our ESRD group and the medial 
temporal group in the Myers et al. (2003) study, the absolute levels of learning in Phase 2 are 
very different.  The MT patients of Myers et al. not only learned in un-exposed Phase 2 as 
quickly as controls, but they also learned in exposed Phase 2 more quickly than controls, with 
fewer errors. In our ESRD group, the patients learned at the same rate as the exposed controls 
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(a similar number of errors was made), but learned at a slower rate than the un-exposed 
controls (making about 2.5 times more errors, though the difference was not significant after 
Bonferroni correction). Myers et al. suggest that medial temporal damage is facilitating this 
simple stimulus-response learning because of reduced interference from the damaged 
hippocampus (animal studies have shown that lesions to the hippocampal region result in 
faster stimulus-response learning [Eichanbaum, Otto & Cohen, 1994]). However, we found 
no evidence for any such facilitation in our ESRD group. In their PD patients, Myers et al 
found a ‘reversed’ exposure effect. That is, in Phase 2, their unexposed group made many 
more errors than did the exposed group, unlike the pattern in ESRD, in which our unexposed 
patient group made slightly fewer errors than the exposed group. Thus, although the pattern 
of results in our controls was similar to that of Myers et al., the results of our ESRD group 
differed from those of both their MT and their PD patients. 
One explanation for the pattern found in our ESRD group is that, rather than a facilitation of 
learning, as observed in MT patients, simple forgetting may be responsible - patients are less 
able to recall the stimulus information present in Phase 1. Bouten (1993) uses the term 
‘proactive interference’ to describe the learned irrelevance demonstrated in the control group, 
in which the negative influence from observing the uncorrelated stimulus in Phase 1 is 
influencing performance in Phase 2. In ESRD, on the other hand, there is no interference 
between the two phases, as what has been observed during Phase 1 is simply forgotten. 
Examples of accelerated forgetting have been demonstrated in Alzheimer’s patients with 
temporal lobe pathology (Christensen, Kopelman, Stanhope, Lorentz & Owen, 1998; Hart, 
Kwentus, Taylor & Harkins, 1987) and patients with unilateral and bilateral hippocampal 
lesions, who have shown immediate (Parkin & Leng, 1988) and one minute delayed 
accelerated forgetting (Frisk & Milner, 1990). Kopelman and Stanhope (1997) demonstrated 
accelerated forgetting in amnesia patients with temporal lobe damage. During free recall of 
pictures of objects, greater accelerated forgetting was observed in the temporal lobe patients, 
compared to a control group, between periods of 20 seconds and 10 minutes. This hypothesis 
may explain the pattern of results in our ESRD group.  Patients are processing Phase 1 
correctly, in the same way as controls, but between Phase 1 and Phase 2, stimuli observed in 
Phase 1, stored by the control group for future use, are simply forgotten in the patient group. 
There is evidence for impairment of short-term memory in ESRD. Kurella et al (2004) found 
ESRD patients to be significantly worse on the California Verbal Learning Test. Similarly, 
Elias et al (2009) found patients with low kidney function to be worse on tests of immediate 
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visual memory than were those whose kidney function was less impaired. These results, and 
our own, suggest impairment of temporal lobe processing in the illness.  
Another possibility is that patients may be processing Phase 1 in a qualitatively different way 
to the controls (in other words, the exposed group may be ignoring the colours in Phase 1), so 
that there is no stored information to affect subsequent processing in Phase 2. However, at 
this stage it is not clear whether this is due to limitations on attentional resources (and so 
perhaps would implicate the frontal lobes) or some other factor.  
The ESRD results are certainly consistent with a cortical impairment of some kind, perhaps 
involving the frontal and/or temporal lobes. Ruling out an important sub-cortical contribution 
depends in the present context on a comparison with the results of the PD patients of Myers 
et al.  A limitation of that study, as the authors point out, is that the patients were all receiving 
dopaminergic medication, and a dose which alleviated basal ganglia impairment (at least 
partially) might cause hyperactivity of dopaminergic innervation of the frontal lobes.  In 
healthy volunteers, a dopamine agonist (amphetamine) can interfere with latent inhibition 
(Gray, Pickering, Hemsley, Dawling, and Gray, 1992). However, the effect was found to be 
dose dependent, so that, somewhat counterintuitively, a 10 mg dose had no effect whereas a 5 
mg dose did.  Nevertheless, it is possible that at least some of the PD patients in the Myers et 
al study fell in the appropriate dose range to cause changes to the frontal lobes. Thus there is 
uncertainty about whether the pattern of results in the PD patients of Myers et al. reflects 
frontal or subcortical changes (or both). Since the pattern of results in our ESRD patients is 
different from that in the medicated PD patients, and there is evidence for temporal 
impairment in ESRD from studies of immediate memory, we suggest that absence of latent 
learning in ESRD is most consistent with a temporal lobe impairment.  However, without 
further evidence, we cannot be sure whether the whole cortex is affected or whether some 
areas are more susceptible than others. Similarly, we do not assume that subcortical structures 
are immune to the effects of ESRD, since their blood supply will be affected in the same 
ways as that to the cortex. It may be that subcortical processing is more robust, and so less 
prone to impairment caused by degradation of the blood. 
We should note a limitation of the study. ESRD is linked, by cause or effect, to several 
comorbidities (see Table 1.2), which also affect blood supply.  Our sample of patients 
contained enough with a diagnosis of hypertension to make possible a comparison of those 
with and without hypertension. No effect of hypertension was found, perhaps because, once 
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diagnosed, it can be controlled by medication. We cannot rule out the possibility that at least 
some contribution to the impairments we found may be caused by other comorbidities. 
Further studies are needed to disentangle these possible effects on cognition. 
The trend of a rise in number of errors with age in controls is understandable, but the opposite 
trend in patients is puzzling. There was little variation in severity of illness in this patient 
group – by definition, anyone in the end-stage of the disease has kidney function of 
approximately less than 15% of normal (GFR < 15mL/min). It is possible that older brains 
are less susceptible to the changes in blood chemistry caused by ESRD than are younger 
brains, a possibility which needs investigation in future studies. 
In summary, this study provides an insight into the mechanisms underlying the cognitive 
impairment observed in ESRD, suggesting the deficit to be predominantly cortical in nature, 
and implicating the involvement of the temporal lobes. Further investigations building on the 
present results may shed more light on the possible contribution from temporal regions of the 
brain, perhaps with the aid of brain imaging techniques. 
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Appendix A – Word Lists 
 
The following pronounceable nonwords were used in Phase 1: 
melk (signal word) zoch 
tawe   jant 
bije   hund 
morv   sarn 
ratch 
zare 
moel 
slar 
malp 
cort 
slig 
 
The following pronounceable nonwords were used in Phase 2: 
noge   glep 
juff   zoyn 
frod   bola 
forl   hewl 
hoor 
fion 
blae 
dett 
gwan 
vair 
rhyl 
